[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336472-105":59,"doc-detail-336472-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","aspects-and-outcomes-of-surveillance-for-individuals-at-high-risk-of-pancreatic-cancer-review","Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer - Review","","Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer mortality and is usually diagnosed at a late stage, resulting in poor prognosis. Population screening is not recommended due to the relatively low incidence of PDAC, yet surveillance is advised for individuals with a high risk based on genetic predisposition and family history. This review summarizes how high-risk individuals are identified, defines surveillance objectives and targets, describes program organization, reviews outcomes, and presents future perspectives and developments in surveillance strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/aspects-and-outcomes-of-surveillance-for-individuals-at-high-risk-of-pancreatic-cancer-review/336472/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/aspects-and-outcomes-of-surveillance-for-individuals-at-high-risk-of-pancreatic-cancer-review/336472.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is pancreatic cancer surveillance considered for high-risk individuals rather than the general population?","Question",{"text":112,"@type":113},"Population-based screening is not recommended because PDAC incidence is relatively low, which would generate many false positives and unnecessary harm. Surveillance targets individuals at high risk where the disease incidence is increased, making detection more beneficial.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are individuals classified as high-risk for PDAC in this review?",{"text":117,"@type":113},"High-risk individuals have an increased PDAC risk based on family history and/or germline pathogenic variant status, requiring a minimum lifetime risk of at least 5%. Different pathogenic variant carriers can have distinct cumulative incidences, reflecting the complexity of selecting high-risk groups.",{"name":119,"@type":110,"acceptedAnswer":120},"What key questions does the review aim to address about surveillance outcomes?",{"text":121,"@type":113},"The review highlights uncertainty about whether surveillance increases resection rates, reduces unnecessary surgeries, and improves survival compared with no surveillance. It also outlines how surveillance programs are organized and summarizes reported outcomes among high-risk individuals.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336472,1791370591,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Familial Cancer (2024) 23:323–339  \n[https://doi.org/10.1007/s10689-024-00368-1](https://doi.org/10.1007/s10689-024-00368-1)  \nAspects and outcomes of surveillance for individuals at high‑risk of pancreatic cancer  \nAleksander M. Bogdanski1 · Jeanin E. van Hooft1 · Bas Boekestijn2 · Bert A. Bonsing3 · Martin N. J. M. Wasser2 ·  \nDerk C. F. Klatte1 · Monique E. van Leerdam1,4  \nReceived: 5 January 2024 / Accepted: 24 February 2024 / Published online: 15 April 2024 © The Author(s) 2024  \nAbstract  \nPancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths and is associated with a poor prognosis. The majority of these cancers are detected at a late stage, contributing to the bad prognosis. This underscores the need for novel, enhanced early detection strategies to improve the outcomes. While population-based screening is not recommended due to the relatively low incidence of PDAC, surveillance is recommended for individuals at high risk for PDAC due to their increased incidence of the disease. However, the outcomes of pancreatic cancer surveillance in high-risk individuals are not sorted out yet. In this review, we will address the identification of individuals at high risk for PDAC, discuss the objectives and targets of surveillance, outline how surveillance programs are organized, summarize the outcomes of highrisk individuals undergoing pancreatic cancer surveillance, and conclude with a future perspective on pancreatic cancer surveillance and novel developments.  \nKeywords Pancreatic ductal adenocarcinoma · Pancreatic cancer surveillance · High-risk individuals · Early detection  \nBackground  \nPancreatic ductal adenocarcinoma (PDAC) is a major health problem with a growing incidence [1] . It is anticipated that it will become the second-leading cause of cancer-related deaths by 2030 [2] . PDAC has a poor prognosis with a 5-year survival rate of less than 10%[3] . While surgical resection is the only curative treatment, 80% of PDACs are unresectable at presentation [4 , 5] . This underscores the necessity for early detection. Nonetheless, pancreatic cancer screening of the general population is not feasible due to the relatively low incidence of this disease, with 13.3 cases per  \n* Aleksander M. Bogdanski  \n[A.M.Bogdanski@lumc.nl](A.M.Bogdanski@lumc.nl)  \n1 Department of Gastroenterology and Hepatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands  \n2 Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands  \n3 Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands  \n4 Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands  \n100,000 individuals per year [6]. Even a highly accurate test would result in many false-positively diagnosed individuals, who would be subjected to unnecessary harm including operation, excessive psychological burden following from screening, and would lead to high costs [7, 8]. Accordingly, pancreatic cancer screening of the general population is currently not recommended by guidelines [9–12] . While that is the case, pancreatic screening may prove more effective when applied to subpopulations at an increased risk for PDAC [13] .  \nInterestingly, it is known that up to 10% of individuals with PDAC have an underlying genetic predisposition [14] . The incidence of PDAC among these high-risk individuals (HRIs) is higher compared to that of the general population, making surveillance more appropriate in that subpopulation. Although data on long-term screening results are recently starting to be published, several questions persist. It remains unclear whether surveillance results in an increased resection rate of PDAC, avoids an excessive number of unnecessary surgeries and improves survival outcomes compared to no surveillance. Therefore, the aim of this review is to present a comprehensive overview of pancreatic cancer surveillance among HRIs. We will","cbCaijzgZam24TP6","https://ap.wps.com/l/cbCaijzgZam24TP6","pdf",1277037,17,"English","# Abstract\n# Background\n# Selection of individuals at high-risk\n## Family history and germline pathogenic variants","[{\"question\":\"Why is pancreatic cancer surveillance considered for high-risk individuals rather than the general population?\",\"answer\":\"Population-based screening is not recommended because PDAC incidence is relatively low, which would generate many false positives and unnecessary harm. Surveillance targets individuals at high risk where the disease incidence is increased, making detection more beneficial.\"},{\"question\":\"How are individuals classified as high-risk for PDAC in this review?\",\"answer\":\"High-risk individuals have an increased PDAC risk based on family history and/or germline pathogenic variant status, requiring a minimum lifetime risk of at least 5%. Different pathogenic variant carriers can have distinct cumulative incidences, reflecting the complexity of selecting high-risk groups.\"},{\"question\":\"What key questions does the review aim to address about surveillance outcomes?\",\"answer\":\"The review highlights uncertainty about whether surveillance increases resection rates, reduces unnecessary surgeries, and improves survival compared with no surveillance. It also outlines how surveillance programs are organized and summarizes reported outcomes among high-risk individuals.\"}]","Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer - Review | PDF",1790015190,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fe7f8470d976069d304af251a7dd380.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d874b4732c27dc525583a8677c791e55.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3032ed18e8788fd2c051188daded08e.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b6f7f9d166fa0e0010041bf4f2f910e.webp",980,1301]